Gene · 599
Papers4,142
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,142
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrating bulk RNA-seq and scRNA-seq data to explore diverse cell death patterns and develop a programmed cell death-related relapse prediction model in pediatric B-ALL. | Sci Rep | 2025 | 39955305 | PubTator, text mining | PubMed |
| Insights on the crosstalk among different cell death mechanisms. | Cell Death Discov | 2025 | 39929794 | PubTator, text mining | PubMed |
| RNA Sequencing Data Analysis of Oligoasthenoteratozoospermia Patients' Sperms and Effects of Curcumin on the Expression of Some Genes during Sperm Cryopreservation and Freeze-Thawing Process. | Iran J Public Health | 2025 | 39902348 | PubTator, text mining | PubMed |
| Onvansertib and Navitoclax Combination as a New Therapeutic Option for Mucinous Ovarian Carcinoma. | Int J Mol Sci | 2025 | 39859203 | PubTator, text mining | PubMed |
| Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics. | Chem Rev | 2025 | 39818743 | PubTator, text mining | PubMed |
| Senolysis by ABT-263 is associated with inherent apoptotic dependence of cancer cells derived from the non-senescent state. | Cell Death Differ | 2025 | 39706991 | PubTator, text mining | PubMed |
| HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells. | Cell Death Differ | 2025 | 39627361 | PubTator, text mining | PubMed |
| H4K20me3-Mediated Repression of Inflammatory Genes Is a Characteristic and Targetable Vulnerability of Persister Cancer Cells. | Cancer Res | 2025 | 39476057 | PubTator, text mining | PubMed |
| Lipid peroxidation products induce carbonyl stress, mitochondrial dysfunction, and cellular senescence in human and murine cells. | Aging Cell | 2025 | 39394673 | PubTator, text mining | PubMed |
| TPepPro: a deep learning model for predicting peptide-protein interactions. | Bioinformatics | 2024 | 39585721 | PubTator, text mining | PubMed |
| Comprehensive functional evaluation of head and neck squamous cell carcinoma with BH3-profiling demonstrates apoptotic competency and therapeutic efficacy of BH3-mimetics. | Oral Oncol | 2024 | 39423550 | PubTator, text mining | PubMed |
| HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma. | J Exp Clin Cancer Res | 2024 | 39243039 | PubTator, text mining | PubMed |
| Dissecting the neuroprotective interaction between the BH4 domain of BCL-w and the IP3 receptor. | Cell Chem Biol | 2024 | 39067448 | PubTator, text mining | PubMed |
| Cell Proliferation and Apoptosis-Key Players in the Lung Aging Process. | Int J Mol Sci | 2024 | 39063108 | PubTator, text mining | PubMed |
| Delineating the Antiapoptotic Property of Apigenin as an Antitumor Agent: A Computational and In Vitro Study on HeLa Cells. | ACS Omega | 2024 | 38882173 | PubTator, text mining | PubMed |
| Berberis vulgaris L. Root Extract as a Multi-Target Chemopreventive Agent against Colon Cancer Causing Apoptosis in Human Colon Adenocarcinoma Cell Lines. | Int J Mol Sci | 2024 | 38732003 | PubTator, text mining | PubMed |
| Effective Targeting of Melanoma Cells by Combination of Mcl-1 and Bcl-2/Bcl-xL/Bcl-w Inhibitors. | Int J Mol Sci | 2024 | 38542429 | PubTator, text mining | PubMed |
| AMPK inhibition sensitizes acute leukemia cells to BH3 mimetic-induced cell death. | Cell Death Differ | 2024 | 38538744 | PubTator, text mining | PubMed |
| Tumor-derived miR-6794-5p enhances cancer growth by promoting M2 macrophage polarization. | Cell Commun Signal | 2024 | 38521953 | PubTator, text mining | PubMed |
| Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop immunotherapy. | Cancer Lett | 2024 | 38408603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/599/papers?page=4